Prostatis Group LLC Baxter International Inc Transaction History

Prostatis Group LLC

  • $215 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Mar 23, 2023
SELL
$78.66 - $94.14 $7.64 Million - $9.15 Million
-97,156 Closed
0 $0
Q1 2020

Mar 23, 2023
SELL
$71.57 - $93.3 $714,984 - $932,067
-9,990 Reduced 9.32%
97,156 $159 Million
Q4 2019

Mar 23, 2023
BUY
$76.7 - $88.45 $8.22 Million - $9.48 Million
107,146 New
107,146 $172 Million

Others Institutions Holding BAX

# of Institutions
1,008
Shares Held
451M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email